Actinium Pharmaceuticals reported $-5.13M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AbbVie USD 3.61B 2.92B Jun/2026
Actinium Pharmaceuticals USD -5.13M 1.75M Sep/2025
Amgen USD 2.38B 556M Jun/2026
Bioline Rx USD -1.6M 635K Mar/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Pfizer USD -248M 2.94B Jun/2026